treatment
treatment
05/19/2022
The FDA has approved a new form of treatment for adults with amyotrophic lateral sclerosis, commonly known as Lou Gehrig disease.
05/19/2022
Cardiometabolic Risk
Cardiometabolic Risk
03/11/2019
In a recent study, researchers investigated the effects of vascular risk factors including blood pressure, smoking status, and diabetes on brain health in older adult patients.
03/11/2019
Cardiometabolic Risk
Cardiometabolic Risk
11/12/2018
Researchers at the APHA’s Annual Meeting & Expo presented their findings on the connection between risk factors for cognitive decline and cardiovascular disease.
11/12/2018
Prevalence
Prevalence
10/04/2018
New study findings show that the lifetime risk of common neurological diseases is extremely high, and that the need for prevention strategies remains a top priority.
10/04/2018
Nutrition
Nutrition
02/01/2018
The Global Council on Brain Health of the AARP has released new consensus statements and recommendations regarding the impact of nutrition on brain health among individuals aged 50 years and older.
02/01/2018
Nutrition
Nutrition
12/21/2017
Increased fish consumption is known to improve cognitive function in children. In a new study, researchers aimed to identify the mediating pathways in this relationship.
12/21/2017
Screening
Screening
07/13/2017
In a recent study, researchers evaluated the role of certain social factors in predicting onset of various neurodegenerative disorders. For details on which mood and behavioral changes predicted Alzheimer...
07/13/2017
Neurological Disorders and Diseases
Neurological Disorders and Diseases
04/27/2017
The US Food and Drug Administration has approved a new option for the treatment of a specific form of Batten disease in pediatric patients aged 3 years and older.
04/27/2017
Screening
Screening
04/13/2017
Researchers found a common biomarker associated with 2 forms of dementia—frontotemporal dementia (FTD) and neuronal ceroid lipofuscinosis (NCL).
04/13/2017
Movement Disorders
Movement Disorders
04/04/2017
The US Food and Drug Administration has approved Austedo (deutetrabenazine) tablets for the treatment of chorea in patients with Huntington disease.
04/04/2017